Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
about
Treatment for osteoporosis in people with ß-thalassaemiaTreatment for osteoporosis in people with ß-thalassaemiaEfficacy of zoledronic acid in treatment of osteoporosis in men and women-a meta-analysis.Evaluation of bone mineral density in patients with hemoglobin H disease.Bisphosphonates in the treatment of thalassemia-associated osteoporosis.Radiography finding in the jaws in children taking bisphosphonate.Bisphosphonates use in children.Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials.Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.Which pamidronate protocol is the best for treating osteoporosis in beta-thalassemia major?Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis.Long-term effects of pamidronate in thalassemic patients with severe bone mineral density deficits.Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).Fractures and Low Bone Mineral Density in Patients with Beta Thalassemia Major.Zoledronic Acid for Treatment of Low Bone Mineral Density in Patients with Beta Thalassemia Major
P2860
Q24186036-C106C319-2631-4F24-A482-6B5F65281F54Q24200472-84E8CFF9-3096-45C5-B1C1-7A8A9A941510Q35643754-C1B6F56A-CC99-46B4-9F5D-698BBEE1AAABQ36038928-80712E83-0004-4664-98D6-69BE4932A333Q37117363-BD3DB3BC-5D25-4FD0-A4FD-3D58BA421DBDQ37579282-5A981EDA-FAB0-4156-ABDD-98ACA0899FC0Q38039262-C7394B54-0858-426E-9B1E-6CE1F7644A66Q38205707-DC6D097D-3A74-4394-85D9-B41A9E2B1AF5Q38471926-F1FCBB37-64AD-4918-804F-A4F8782D2D6AQ38922341-741D4151-8C7A-47F3-ABFA-3166CBAD9BA3Q40248622-588240B3-673C-4B8E-88B5-212B8932A4A8Q40703352-FF974150-05D9-45E7-9120-CBA781918520Q43265083-C37FDA5C-2FFF-43D9-A492-8E56A2B63454Q45732733-AD84F635-A692-47E0-B2F2-8B0A5EE6531AQ49338163-9E8E3BA9-1035-4019-8EE6-7DBC87C0A126Q58125050-5C072A62-EFEE-43C4-A914-40400BCED684
P2860
Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
@en
Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
@nl
type
label
Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
@en
Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
@nl
prefLabel
Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
@en
Bisphosphonates in the treatment of thalassemia-induced osteoporosis.
@nl
P2093
P356
P1476
Bisphosphonates in the treatment of thalassemia-induced osteoporosis
@en
P2093
P2888
P304
P356
10.1007/S001980200087
P407
P577
2002-08-01T00:00:00Z